...
首页> 外文期刊>Daru Journal of pharmaceutical sciences. >Investigation of formulation variables affecting the properties of lamotrigine nanosuspension using fractional factorial design
【24h】

Investigation of formulation variables affecting the properties of lamotrigine nanosuspension using fractional factorial design

机译:使用分数阶因子设计研究影响拉莫三嗪纳米悬浮液性能的配方变量

获取原文
           

摘要

Background and the purpose of the studyLamotrigine (LMG) undergoes extensive hepatic metabolism upon oral administration and its absorption is affected in the presence of food. This study was aimed to develop nanosuspension of LMG and investigate its formulation characteristics using L9 orthogonal array.MethodsNanosuspension was prepared using emulsification-solvent diffusion method. All the formulations were subjected to in-vitro evaluation and the statistically optimized one was used for stability, scanning electron microscopic and differential scanning calorimetric studies.ResultsNanoparticles were spherical with little surface adsorbed drug. Formulation characteristics in terms of size, zeta potential, polydispersity index (PDI), entrapment efficiency (EE), drug content and in vitro drug release were consistent and within their acceptable range. All the batches provided a burst release profile during first 1 hr, followed by a controlled release extending up to 24 hrs. The values of n in Peppas model ranged between 0.2-0.4 for all the formulations indicative of Fickian release mechanism. The formulation remained reasonably stable up to 3 months. No interaction was observed among the drug and polymers.Major conclusionResults of in vitro drug release studies suggested that nanosuspension might be used as a sustained delivery vehicle for LMG. Statistical analysis revealed that size of the nanoparticles was most strongly affected by stabilizer type while EE was influenced by the drug-to-polymer ratio.
机译:研究背景和目的拉莫三嗪(LMG)口服后会发生广泛的肝代谢,在食物中会影响其吸收。本研究旨在开发LMG的纳米悬浮液,并利用L9正交阵列研究其制备特性。方法采用乳化-溶剂扩散法制备纳米悬浮液。所有制剂均经过体外评估,经统计学优化后的制剂用于稳定性,扫描电子显微镜和差示扫描量热法研究。结果纳米颗粒呈球形,表面吸附的药物很少。在大小,ζ电位,多分散性指数(PDI),包封率(EE),药物含量和体外药物释放方面的制剂特性是一致的,并且在可接受的范围内。所有批次均在最初的1小时内提供了突发释放特性,随后是长达24小时的控制释放。在Peppas模型中,对于所有表明Fickian释放机理的制剂,n的值在0.2-0.4之间。该制剂在3个月内保持合理的稳定性。主要结论结论体外药物释放研究的结果表明,纳米混悬剂可作为LMG的缓释载体。统计分析表明,纳米颗粒的尺寸受稳定剂类型的影响最大,而EE受药物与聚合物比率的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号